Angiotensin-Converting Enzyme Inhibitor versus Angiotensin 2 Receptor Antagonist Therapy and the Influence of Angiotensin-Converting Enzyme Gene Polymorphism in IgA Nephritis

Keng-Thye Woo, Yeow‐Kok Lau, Choong-Meng Chan, Kok‐Seng WongAnnals 2008 · DOI

Abstract

ATRA therapy was found to be effective in retarding disease progression to ESRF in IgAN compared to ACEI therapy. Genotyping showed better response to ATRA therapy only for those with the II genotype.
BibTeX
@article{woo2008angiotensin,
  author = {Keng-Thye Woo and Yeow‐Kok Lau and Choong-Meng Chan and Kok‐Seng Wong},
  title = {{Angiotensin-Converting Enzyme Inhibitor versus Angiotensin 2 Receptor Antagonist Therapy and the Influence of Angiotensin-Converting Enzyme Gene Polymorphism in IgA Nephritis}},
  journal = {Annals},
  year = {2008},
  doi = {10.47102/annals-acadmedsg.v37n5p372},
}

Loading related content...

Figure